Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,518 public trials 2,834 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain

NCT04906447

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation

NCT04285567

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Medical Center of Aurora Aurora, Colorado, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
  • University of Tennessee Medical Center;Office of Clinical Trials Knoxville, Tennessee, United States
  • Oncology & Hematology Associates of Southwest Virginia, Inc._Goldschmidt Roanoke, Virginia, United States
View all 40 locations
View Trial Details
Completed

A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients

NCT06521931

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +2 more
Locations
  • Affiliated Hospital of Hebei University Baoding, Hebei, China
  • The First Affiliated Hospital of Henan University of Science and Technology Luoyang, Henan, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Yiyang Central Hospital Yiyang, Hunan, China
View Trial Details
Completed

Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma

NCT01919086

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
View Trial Details

Related conditions